Columbia-Suicide Severity Rating Scale (C-SSRS)
The C-SSRS is a validated screening and assessment tool that systematically evaluates the presence and severity of suicidal ideation and behavior, and should be used as a first-line screening instrument in both general and at-risk populations according to the most recent 2024 VA/DOD guidelines 1.
What the C-SSRS Measures
The C-SSRS assesses two primary domains:
- Suicidal Ideation Severity (scored 0-5): Captures the spectrum from passive wish to be dead through active ideation with specific plan and intent
- Suicidal Behavior: Documents actual suicide attempts, preparatory acts, and non-suicidal self-injury
- Intensity of Ideation (scored 0-25): Evaluates frequency, duration, controllability, deterrents, and reasons for ideation
The scale distinguishes between active suicidal ideation (with intent to act) and passive ideation (wish to be dead without intent), which is clinically critical for risk stratification 2.
Clinical Application and Guideline Support
The 2024 VA/DOD guidelines specifically recommend the C-SSRS Screener as a validated measure for identifying patients at risk for suicide-related behavior in both general populations and populations at increased risk 1. This represents a weak-for recommendation based on systematic evidence review.
How to Use It in Practice:
- Initial Screening: Administer the brief screener version (6 yes/no questions) to identify any suicidal ideation or behavior
- Risk Stratification: If positive, the full C-SSRS quantifies severity through hierarchical questions that progress from least to most severe ideation
- Behavioral Assessment: Document lifetime and recent (past 3 months) suicide attempts and preparatory behaviors
- Longitudinal Tracking: The scale is sensitive to change over time, making it useful for monitoring treatment response 3
Psychometric Properties and Limitations
The C-SSRS demonstrates strong clinical discrimination with excellent ability to distinguish suicide attempters from non-attempters (AUC = 0.93) 4. The scale showed good convergent validity with other suicide measures and high sensitivity/specificity for suicidal behavior classifications 3.
Critical Caveats:
Internal consistency is problematic: Recent 2026 data from a 15-year Brazilian cohort study revealed low internal consistency (KR-20 = 0.57 for severity; ω = 0.67 for intensity) and a two-factor structure rather than unidimensional scoring 4. This means you should not treat C-SSRS scores as simple continuous indices—instead, focus on categorical risk levels and specific endorsed items.
A 2014 critique highlighted that the C-SSRS may miss certain combinations of suicidal ideation and behavior (type II errors) due to navigation flaws and ambiguous wording 5. Despite these psychometric concerns, the scale maintains strong predictive validity: participants with intent or intent-with-plan at baseline had significantly higher odds of subsequent suicide attempts 3.
Predictive Value
Prior self-harm is the strongest longitudinal predictor (IRR = 2.06) with dose-response relationships across risk categories 4. The highest two levels of ideation severity (intent to act, with or without plan) specifically predict future attempts, whereas lower-level ideation alone may not 3.
Important Clinical Pitfalls
- Do not rely solely on total scores: The multidimensional structure means specific item endorsements (particularly intent and plan) carry more weight than aggregate scores 4
- Risk stratification tools lack evidence: While the C-SSRS identifies risk, the 2024 guidelines explicitly state there is insufficient evidence to recommend any specific method for determining level of suicide risk 1
- Screening alone is insufficient: The guidelines note insufficient evidence that screening programs reduce suicide or attempts—screening must be coupled with comprehensive assessment and intervention 1
Comprehensive Assessment Beyond C-SSRS
When a patient screens positive, expand assessment to include 1:
- History of self-directed violence and prior attempts
- Current psychiatric diagnoses and treatment history
- Acute psychiatric symptoms (depression, psychosis, agitation)
- Social determinants: housing instability, financial stress, isolation
- Access to lethal means (firearms, medications, other methods)
- Physical health conditions (chronic pain, terminal illness)
- Recent adverse life events (loss, trauma, legal problems)
The C-SSRS provides the structured ideation/behavior assessment, but clinical judgment incorporating these broader risk factors guides management decisions.